Harushige Yokota
Saitama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
A confirmatory trial of hysterectomy with minimal parametrectomy for stage IB1 cervical cancer involving a tumor diameter of 2 cm or less: a Japan Clinical Oncology Group study (JCOG1101).
Journal: Journal of gynecologic oncology
Published: August 11, 2025
Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancer.
Journal: Cancer medicine
Published: November 23, 2023
Correction to: Risk assessment in the patients with uterine cervical cancer harboring intermediate risk factors after radical hysterectomy: a multicenter, retrospective analysis by the Japanese Gynecologic Oncology Group.
Journal: International journal of clinical oncology
Published: July 12, 2022
Regional differences in human papillomavirus type 52 prevalence among Japanese women with cervical intraepithelial neoplasia†.
Journal: Japanese journal of clinical oncology
Published: January 06, 2022
Risk assessment in the patients with uterine cervical cancer harboring intermediate risk factors after radical hysterectomy: a multicenter, retrospective analysis by the Japanese Gynecologic Oncology Group.
Journal: International journal of clinical oncology
Published: December 02, 2021
Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women.
Journal: Cancer science
Published: November 25, 2021
Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 02, 2019
Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer.
Journal: Oncotarget
Published: August 10, 2017
Application of deep learning to the classification of images from colposcopy.
Journal: Oncology letters
Published: May 13, 2017
Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 20, 2016
Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients.
Journal: International journal of clinical oncology
Published: May 08, 2015
Last Updated: 09/26/2026